Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (68)
  • 2024 (67)
  • 2023 (106)
  • 2022 (92)
  • 2021 (76)
  • 2020 (36)
  • 2019 (19)
  • 2018 (4)
  • 2017 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Take Back Day (246)
  • Diversion Division (242)

Drug Name

  • Opioids (44)
  • Oxycodone (42)
  • Fentanyl (29)
  • Hydromorphone (15)
  • Synthetic Opioids (11)
  • Benzodiazepines (7)
  • Methamphetamine (7)
  • Morphine (6)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Cocaine (2)
  • Heroin (2)
  • Marijuana (Cannabis) (2)
  • Barbiturates (1)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Seattle (47)
  • Washington, DC (40)
  • New England (36)
  • Sede (32)
  • New York (30)
  • Chicago (26)
  • Atlanta (24)
  • New Jersey (23)
  • Omaha (23)
  • Miami (20)
  • Houston (19)
  • Phoenix (18)
  • St. Louis (18)
  • El Paso (17)
  • Louisville (17)
  • New Orleans (17)
  • Rocky Mountain (15)
  • San Diego (12)
  • San Francisco (10)
  • Dallas (8)
  • Philadelphia (8)
  • Los Angeles (6)
  • Detroit (2)
Clear All Results
PRESS RELEASE

Charlottesville Dermatologist Sentenced for Diverting Pain Medication

Julio 30, 2021
CHARLOTTESVILLE, Va., – A dermatologist formerly employed at a dermatological practice in the City of Charlottesville was sentenced last week to 12 months probation, including a period of home confinement and electronic monitoring, for using the Drug Enforcement Administration (DEA) registration number of her co-workers to obtain prescription opioid pain...
Julio 30, 2021
PRESS RELEASE

North Carolina Man Pleads Guilty to Conspiring to Distribute Suboxone, Oxycodone, other Pain Medications

Julio 29, 2021
ABINGDON, Va., – A Dobson, North Carolina man pleaded guilty yesterday to conspiring to distribute medically illegitimate prescriptions for Schedule II opioids and Suboxone, as well as conspiring to use, in the course of the distribution of controlled substances, the DEA registration number of another person. According to court documents...
Julio 29, 2021
PRESS RELEASE

Two Chicago Area Physicians Indicted on Narcotics and Health Care Fraud

Julio 27, 2021
CHICAGO — Special Agent in Charge Robert J. Bell, Drug Enforcement Administration-Chicago Division and John R. Lausch, Jr., United States Attorney for the Northern District of Illinois announced that two suburban Chicago physicians have been indicted on federal criminal charges for allegedly prescribing opioids to individuals who lacked a legitimate...
Julio 27, 2021
PRESS RELEASE

Arlington Doctor and Nurse Practitioner Found Guilty of Operating a Pill Mill

Julio 07, 2021
DALLAS - An Arlington physician has been convicted of drug crimes, announced today by DEA Dallas Special Agent in Charge Eduardo A. Chávez Following five days of trial, a federal jury convicted physician Clinton Battle, 68, of one count of conspiracy to distribute controlled substances and one count of distribution...
Julio 07, 2021
PRESS RELEASE

DEA Washington Division Issues Warning: “One Pill Can Kill”

Junio 29, 2021
Washington, D.C. – Jarod Forget, Special Agent in Charge (SAC) of the DEA Washington Division, is alerting all area residents to an increase in drug overdose deaths tied to counterfeit pills containing the powerful synthetic opioid, fentanyl. Manufactured by Mexican drug trafficking organizations, and marketed as a medication such as...
Junio 29, 2021
PRESS RELEASE

Oklahoma City Doctor Pays $325,000 to Settle Civil Penalty Claims

Junio 23, 2021
OKLAHOMA CITY - Albert T. Nguyen, M.D., of Oklahoma City, paid $325,000 to settle civil penalty claims stemming from allegations that he violated the Comprehensive Drug Abuse Prevention and Control Act of 1970 and its regulations. The settlement was announced by Eduardo A. Chávez, Special Agent in Charge of the...
Junio 23, 2021
PRESS RELEASE

Pair Plead Guilty to Drug Testing Kickback Scheme

Junio 21, 2021
ABINGDON, Va. – A Miami, Florida man pleaded guilty last week to conspiring with a Bristol, Tennessee man to pay and receive kickbacks. According to court documents, Michael Olshavsky, 51, of Miami, Florida, and John Paul Linke, 57, of Bristol, Tenn., conspired to receive and pay kickbacks to encourage urine...
Junio 21, 2021
PRESS RELEASE

U.S. Navy Petty Officer Pleads Guilty to Role in Multi-State Anabolic Steroid Trafficking Network

Junio 08, 2021
NORFOLK, Va. – Today, a Jacksonville, Florida man was the sixth and final defendant to enter a guilty plea for his role in a multi-state anabolic steroid conspiracy that operated in multiple states across the country. According to court documents, law enforcement received information in February 2020 that Erik Eckert...
Junio 08, 2021
PRESS RELEASE

Manager of Pain Clinic, Her Boyfriend, and Customers Facing Federal Charges for a Drug Distribution Conspiracy

Mayo 19, 2021
Baltimore, MD – A criminal complaint has been filed charging the manager of a pain clinic, her boyfriend, and several customers with conspiracy to distribute controlled substances, including oxycodone and oxymorphone. The defendants charged in the criminal complaint are: Monica Raynette Clark age 31, of Waldorf, Maryland; Michael Tyrone Scott...
Mayo 19, 2021
PRESS RELEASE

Bluefield Doctor Sentenced to Federal Prison on Misbranding Charge

Mayo 13, 2021
ABINGDON, Va. – A family medicine physician in Bluefield, Virginia, was sentenced yesterday to one month in prison on a charge of misbranding Schedule II controlled substances to three individuals, two of whom his office staff called “back door patients.” According to court documents, between December 2014 and January 2016...
Mayo 13, 2021
Showing 381 - 390 of 469 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 35
  • Página 36
  • Página 37
  • Página 38
  • Current page 39
  • Página 40
  • Página 41
  • Página 42
  • Página 43
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster